Felodipine

非洛地平

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFelodipine
Drug Alias Name非氯地平felodipinumfelodipino费乐地平Hydac +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryUnited States
Original Approved Date1991/07/25
Country/TerritoryUnited StatesIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceutical Co Ltd
Inactive CompaniesOverseas Pharmaceuticals LtdTorrent Pharmaceuticals LtdAstrazeneca Plc
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC08CA02
Related LinksWikipediaDrugBankKEGG